Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 2, 2008, Pages 102-107

  KuKanich, B ^a   Coetzee, J F ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIGLYDE V; AMIKACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; SPECIES DIFFERENCE;

CANIS FAMILIARIS;

EID: 40149108072     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00938.x     Document Type: Article

References (13)

1. Arnoff, G.R., Pottratz, S.T., Brier, M.E., Walker, N.E., Fineburg, N.S., Glant, M.D. & Luft, F.C. (1983) Aminoglycoside accumulation kinetics in rat renal parenchyma. Antimicrobial Agents of Chemotherapy, 23, 74–78.
2. Baggot, J.D., Ling, G.V. & Chatfield, R.C. (1985) Clinical pharmacokinetics of amikacin in dogs. American Journal of Veterinary Research, 46, 1793–1796.
3. Bartal, C., Danon, A., Schlaeffer, F., Reisenberg, K., Alkan, M., Smoliakov, R., Sidi, A. & Almog, Y. (2003) Pharmacokinetic dosing of aminoglycosides: a controlled trial. American Journal of Medicine, 114, 194–198.
4. Begg, E.J. & Barclay, M.L. (1995) Aminoglycosides–50 years on. British Journal of Clinical Pharmacology, 39, 597–603.
5. Cabana, B.E. & Taggart, J.G. (1973) Comparative pharmacokinetics of BB‐K8 and kanamycin in dogs and humans. Antimicrobial Agents and Chemotherapeutics, 3, 478–483.
6. Craig, W.A., Redington, J. & Ebert, S.C. (1991) Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. Journal of Antimicrobial Chemotherapy, 27 (Suppl. C), 29–40.
7. Drost, W.T., Couto, C.G., Fischetti, A.J., Mattoon, J.S. & Iazbik, C. (2006) Comparison of glomerular filtration rate between greyhounds and non‐Greyhound dogs. Journal of Veterinary Internal Medicine, 20, 544–546.
8. Gunn, H.M. (1978) The proportions of muscle, bone and fat in two different types of dog. Research in Veterinary Science, 24, 277–282.
9. KuKanich, B., Coetzee, J.F., Gehring, R. & Hubin, M. (2007) Comparative disposition of pharmacologic markers for cytochrome P‐450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs. Journal of Veterinary Pharmacology and Therapeutics, 30, 314–319.
10. Maglio, D., Nightingale, C.H. & Nicolau, D.P. (2002) Extended interval aminoglycoside dosing: from concept to clinic. International Journal of Antimicrobial Agents, 19, 341–348.
11. Moore, R.D., Smith, C.R. & Lietman, P.S. (1984) Association of aminoglycoside plasma levels with therapeutic outcome in gram‐negative pneumonia. American Journal of Medicine, 77, 657–662.
12. Moore, R.D., Lietman, P.S. & Smith, C.R. (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. Journal of Infectious Diseases, 155, 93–99.
13. Rougier, F., Ducher, M., Maurin, M., Corvaisier, S., Claude, D., Jelliffe, R. & Maire, P. (2003) Aminoglycoside dosages and nephrotoxicity: quantitative relationships. Clinical Pharmacokinetics, 42, 493–500.